The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation

Geir Hetland, Egil Johnson, Torstein Lyberg, Gunnar Kvalheim, Geir Hetland, Egil Johnson, Torstein Lyberg, Gunnar Kvalheim

Abstract

The medicinal mushroom Agaricus blazei Murill from the Brazilian rain forest has been used in traditional medicine and as health food for the prevention of a range of diseases, including infection, allergy, and cancer. Other scientists and we have examined whether there is scientific evidence behind such postulations. Agaricus blazei M is rich in the immunomodulating polysaccharides, β-glucans, and has been shown to have antitumor, anti-infection, and antiallergic/-asthmatic properties in mouse models, in addition to anti-inflammatory effects in inflammatory bowel disease patients. These effects are mediated through the mushroom's stimulation of innate immune cells, such as monocytes, NK cells, and dendritic cells, and the amelioration of a skewed Th1/Th2 balance and inflammation.

Figures

Figure 1
Figure 1
Agaricus blazei Murill. Photo NutriCon. The mushroom is cultivated commercially for the health food market in Japan, China, and Brazil. The AbM-based AndoSan extract is produced in Japan and developed and distributed by ImmunoPharma AS, Oslo, Norway.
Figure 2
Figure 2
5-6-week-old female inbred NIH/Ola mice were given either 200 μL of AndoSan AbM extract or phosphate-buffered saline (PBS) intragastrically a day before i.p. injection of 1 million colony-forming units of Streptococcus pneumoniae serotype 6B. There was a significant difference (P < 0.05) between survival after treatment with AndoSan (red line) and PBS (black line). From [14], permission granted for republication by Scand J Immunol, where the figure was originally published.
Figure 3
Figure 3
Female NIH/Ola mice were given either 200 μl of the AndoSan AbM-based extract or PBS intragastrically on day 1 and 10 μg of ovalbumin s.c. on day 0 and again on day 20, before exsanguination for serum on day 26. IgE antiovalbumin levels were lower in the AbM- than in the PBS-treated groups (P = 0.002). Similar results were found if AbM extract or PBS was given 3 weeks after the allergen immunization (not shown, please see [16]). IgG2a antiovalbumin levels (Th1 response) tended to show the opposite result (not shown). From [16], previously published by a BMC journal, which allows reuse.
Figure 4
Figure 4
Bar graphs (mean and standard error the mean (SEM)) with levels of cytokines (pg/mL) MIP-1β, IL-6, IL-8, and MCP-1 (a) and IL-1β, G-CSF, and GM-CSF (b) in stimulated (LPS 1 ng/mL) whole blood ex vivo from eleven patients (unless otherwise stated) with ulcerative colitis prior to (day 0) and after AndoSan consumption for 12 days. Days 0 and 12 after stimulation are depicted by the first and second bars from the left, respectively. For MIP-1β and IL-8, measurements in nine out of ten patients were available. Corresponding measurements from eleven patients with Crohn's disease (unless otherwise stated) were significantly reduced for cytokines MIP-1β, MCP-1, IL-8, and IL-1β (c) and G-CSF, IL-17, GM-CSF, and IL-2 (d). For MIP-1β and IL-8, measurements in ten out of eleven patients were available. Despite remeasurement of MIP-1β after dilution of plasma 1/10, high out of range values still occurred. Accordingly, the true concentrations of MIP-1β were even higher. The P values between the bar graphs compare with the cytokine levels at day 0 prior to the intake of AndoSan. From [24] where the data was part of scatter plots in Scand J Immunol.
Figure 5
Figure 5
Role of the mushroom Agaricus blazei Murill in immune system modulation and disease control. It is assumed that besides β-glucans also other, yet unknown substances in the mushroom, probably of low molecular weight, do parttake in the action. IL-12 is the cytokine from the monocyte/dendritic cell that stimulates Th0.
Figure 6
Figure 6
The Ying and Yang of adaptive immunity. There is a balance between the Th responses in such a way that Th1 inhibits Th2, which inhibits Th17 and which again inhibits the Treg response. “Over-shoot” of Th1 and Th17 responses in susceptible individuals can result in autoimmune disorders. The regulation by T reg cells results in immunosuppression and tolerance. The Agaricus mushroom shifts the Th1/Th2 balance towards increased Th1 response, which in addition to intracellular pathogens also fights cancer.

References

    1. Kerrigan RW. Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia. 2005;97(1):12–24.
    1. Huang N. Brazilian mushroom (Gee Song Rong) In: Huang N, editor. Cultivation of Eigth Rare and Precious Gourmet Mushrooms. Chinese Agriculture University Press; 1997. pp. 95–101.
    1. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Critical Reviews in Immunology. 1999;19(1):65–96.
    1. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei . Biological and Pharmaceutical Bulletin. 2001;24(7):820–828.
    1. Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1→6)-β-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill (’Himematsutake’) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Japanese Journal of Pharmacology. 1994;66(2):265–271.
    1. Czop JK, Valiante NM, Janusz MJ. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors. Progress in Clinical and Biological Research. 1989;297:287–296.
    1. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity. Medical Mycology. 2004;42(6):485–498.
    1. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. Journal of Experimental Medicine. 2003;197(9):1107–1117.
    1. Goodridge HS, Wolf AJ, Underhill DM. β-glucan recognition by the innate immune system. Immunological Reviews. 2009;230(1):38–50.
    1. Endo M, Beppu H, Akiyama H, et al. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochimica et Biophysica Acta. 2010;1800(7):669–673.
    1. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. Journal of Nutrition. 2001;131(5):1409–1413.
    1. Oh TW, Kim YA, Jang WJ, et al. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry. 2010;58(7):4113–4119.
    1. Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AMA, Grinde B. Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer. Scandinavian Journal of Immunology. 2008;68(4):363–370.
    1. Bernardshaw S, Johnson E, Hetland G. An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice. Scandinavian Journal of Immunology. 2005;62(4):393–398.
    1. Bernardshaw S, Hetland G, Grinde B, Johnson E. An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model of fecal peritonitis. Shock. 2006;25(4):420–425.
    1. Ellertsen LK, Hetland G. An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clinical and Molecular Allergy. 2009;7, article no. 6
    1. Romagnani S. The Th1/Th2 paradigm. Immunology Today. 1997;18:263–266.
    1. Takimoto H, Kato H, Kaneko M, Kumazawa Y. Amelioration of skewed Th1/Th2 balance in tumor-bearing and asthma-induced mice by oral administration of Agaricus blazei extracts. Immunopharmacology and Immunotoxicology. 2008;30(4):747–760.
    1. Pelligrini P, Berghella AM, Del Beato T, et al. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progession. Cancer Research. 1998;42:1–8.
    1. Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. European Journal of Immunology. 2002;32(6):1605–1613.
    1. Ellertsen LK, Wiker HG, Egeberg NT, Hetland G. Allergic sensitisation in tuberculosis and leprosy patients. International Archives of Allergy and Immunology. 2005;138(3):217–224.
    1. Hetland G, Løvik M, Wiker HG. Protective effect of β-glucan against Mycobacterium bovis, BCG infection in BALB/c mice. Scandinavian Journal of Immunology. 1998;47(6):548–553.
    1. Johnson E, Førland DT, Sætre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scandinavian Journal of Immunology. 2009;69(3):242–250.
    1. Førland DT, Johnson E, Sætre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease. Scandinavian Journal of Immunology. 2011;73(1):66–75.
    1. Lee IP, Kang BH, Roh JK, Kim JR. Lack of carcinogenicity of lyophilized Agaricus blazei Murill in a F344 rat two year bioassay. Food and Chemical Toxicology. 2008;46(1):87–95.
    1. Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. Journal of Allergy and Clinical Immunology. 2010;125(5):985–992.
    1. Tryggestad AMA, Espevik T, Førland DT, et al. The medical mushroom Agaricus blazei Murill activates NF-κB via TLR2. In: Proceedings of the 13th International Congress of Immunology; August 2007; Rio de Janeiro, Brazil. p. 1193. P2.23 INI-02 Signalling pathways of innate immune receptors.
    1. Bernardshaw S, Lyberg T, Hetland G, Johnson E. Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo . Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2007;115(6):719–725.
    1. Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AMA, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation. 2005;29(4–6):147–153.
    1. Fitzner N, Clauberg S, Essmann F, Liebmann J, Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clinical and Vaccine Immunology. 2008;15(1):138–146.
    1. Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. International Journal of Gynecological Cancer. 2004;14(4):589–594.
    1. Geddes K, Magalhães JG, Girardin SE. Unleashing the therapeutic potential of NOD-like receptors. Nature Reviews Drug Discovery. 2009;8(6):465–479.
    1. Benko S, Magyarics Z, Szabó A, Rajnavölgyi E. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors. Biological Chemistry. 2008;389(5):469–485.
    1. Suzuki T, Ohno N, Saito K, Yadomae T. Activation of the complement system by (1→3)-β-D-glucans having different degrees of branching and different ultrastructures. Journal of Pharmacobio-Dynamics. 1992;15(6):277–285.
    1. Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. Journal of Hematology &amp; Oncology. 2009;2:p. 25.
    1. Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Structure and Function. 2001;26(2):103–108.
    1. Volman JJ, Helsper JPFG, Wei S, et al. Effects of mushroom-derived β-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-κb transactivation in Caco-2 reporter cells: can effects be explained by structure? Molecular Nutrition and Food Research. 2010;54(2):268–276.
    1. Niu YC, Liu JC, Zhao XM, Wu XX. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo. Oncology Reports. 2009;21(1):145–152.
    1. Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Science. 2004;95(9):758–764.
    1. Fujimiya Y, Suzuki Y, Oshiman KI, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunology Immunotherapy. 1998;46(3):147–159.
    1. Kobayashi H, Yoshida R, Kanada Y, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. Journal of Cancer Research and Clinical Oncology. 2005;131(8):527–538.
    1. Xiaohui T, Lun Z, Wang J, et al. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill. Journal of Lanzhou Medical College. 1994;20:169–171.
    1. Murakawa K, Fukunaga K, Tanouchi M, Hosokawa M, Hossain Z, Takahashi K. Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Murill as an immune respond activator. Journal of Oleo Science. 2007;56(4):179–188.
    1. Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo. Journal of Nutritional Biochemistry. 2009;20(10):753–764.
    1. Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clinical Pharmacology and Therapeutics. 2010;87(4):401–406.
    1. Grinde B, Hetland G, Johnson E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. International Immunopharmacology. 2006;6(8):1311–1314.
    1. Hsu CH, Hwang KC, Chiang YH, Chou P. The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. Journal of Alternative and Complementary Medicine. 2008;14(3):299–301.
    1. Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P. The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine. 2007;13(1):97–102.
    1. Zittermann A. Effects of vitamin K on calcium and bone metabolism. Current Opinion in Clinical Nutrition and Metabolic Care. 2001;4(6):483–487.
    1. Førland DT, Johnson E, Tryggestad AMA, Lyberg T, Hetland G. An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine. 2010;49(3):245–250.
    1. Chen L, Shao HJ, Su YB. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses. International Immunopharmacology. 2004;4(3):403–409.
    1. Chen L, Shao H. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease. Veterinary Immunology and Immunopathology. 2006;109(1-2):177–182.
    1. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology. 2007;148(1):32–46.
    1. Yazawa Y, Yokota M, Sugiyama K. Antitumor promoting effect of an active component of polyporus, ergosterol and related compounds on rat urinary bladder carcinogenesis in a short-term test with concanavalin A. Biological and Pharmaceutical Bulletin. 2000;23(11):1298–1302.
    1. Viola A. Improving cancer immunotherapy by preventing chemokine nitration. European Journal of Cancer Supplment. 2010;8:p. 89.
    1. Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2009;31(1):37–49. Article ID bgp272.
    1. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. International Journal of Cancer. 2007;121(11):2373–2380.
    1. Yoshimura K, Kamoto T, Ogawa O, et al. Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: an open-label study. International Journal of Urology. 2010;17(6):548–554.
    1. Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. International Journal of Oncology. 2010;37(6):1529–1536.

Source: PubMed

3
S'abonner